Education
About Us
Working with TipRanks
Follow Us
Annexon Biosciences (ANNX)
NASDAQ:ANNX
Total Valuation
Annexon Biosciences has a market cap or net worth of $206.26M. The enterprise value is $475.23M.
Market Cap$206.26M
Enterprise Value$475.23M
Share Statistics
Annexon Biosciences has 109,709,820 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding109,709,820
Owned by Insiders13.81%
Owned by Institutions0.51%
Financial Efficiency
Annexon Biosciences’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -47.84%.
Return on Equity (ROE)-0.47
Return on Assets (ROA)-0.39
Return on Invested Capital (ROIC)-47.84%
Return on Capital Employed (ROCE)-0.48
Revenue Per Employee0.00
Profits Per Employee-1.38M
Employee Count100
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Annexon Biosciences is -5.10. Annexon Biosciences’s PEG ratio is 0.12.
PE Ratio-5.10
PS Ratio169.36
PB Ratio2.40
Price to Fair Value2.40
Price to FCF-5.97
Price to Operating Cash Flow-5.97
PEG Ratio0.12
Income Statement
In the last 12 months, Annexon Biosciences had revenue of 0.00 and earned -138.20M in profits. Earnings per share was -1.01.
Revenue0.00
Gross Profit0.00
Operating Income-154.07M
Pretax Income-138.20M
Net Income-138.20M
EBITDA-154.07M
Earnings Per Share (EPS)-1.01
Cash Flow
In the last 12 months, operating cash flow was -118.01M and capital expenditures -15.00K, giving a free cash flow of -118.02M billion.
Operating Cash Flow-118.01M
Free Cash Flow-118.02M
Free Cash Flow per Share-1.08
Dividends & Yields
Annexon Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.74
52-Week Price Change-60.00%
50-Day Moving Average2.25
200-Day Moving Average4.87
Relative Strength Index (RSI)48.46
Average Volume (3m)2.29M
Important Dates
Annexon Biosciences upcoming earnings date is May 19, 2025, TBA Not Confirmed.
Last Earnings DateMar 3, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Annexon Biosciences as a current ratio of 10.37, with Debt / Equity ratio of 9.88%
Current Ratio10.37
Quick Ratio10.37
Debt to Market Cap0.04
Net Debt to EBITDA0.13
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Annexon Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Annexon Biosciences EV to EBITDA ratio is -4.44, with an EV/FCF ratio of -5.80.
EV to Sales0.00
EV to EBITDA-4.44
EV to Free Cash Flow-5.80
EV to Operating Cash Flow-5.80
Balance Sheet
Annexon Biosciences has $312.02M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$283.05M billion.
Cash & Marketable Securities$312.02M
Total Debt$0.00
Net Cash-$283.05M
Net Cash Per Share-$2.58
Tangible Book Value Per Share$2.13
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Annexon Biosciences is $14.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$14.20
Price Target Upside655.32% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast―
EPS Growth Forecast43.21%